Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azidamfenicol versus tobramycin eye drops for bacterial conjunctivitis
2013-000923-15Phase 4Completed
- Sponsor
- Farmex
- Start
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in bacterial conjunctivitis (BC), Infective Conjunctivitis and External eye infection comparing Azidamfenicol eye drops with Tobramycin eye drops (2 arms). Primary endpoint: Co-primary endpoints. Started May 2013; status: completed.
02
Drugs
azidamfenicoltobramycin
03
Conditions
bacterial conjunctivitis (BC)Infective ConjunctivitisExternal eye infection
Beyond the preview
Go deeper on 2013-000923-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000923-15.